IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,226,570 | -23.2% | 489,356 | +18.9% | 0.00% | 0.0% |
| Q2 2023 | $2,898,058 | +85.6% | 411,656 | +61.1% | 0.00% | +100.0% |
| Q1 2023 | $1,561,447 | -14.5% | 255,556 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $1,825,981 | -31.8% | 285,756 | +2.2% | 0.00% | -50.0% |
| Q3 2022 | $2,678,000 | -12.6% | 279,556 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $3,064,000 | -38.0% | 277,556 | -6.5% | 0.00% | -33.3% |
| Q1 2022 | $4,941,000 | -5.1% | 296,756 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $5,209,000 | -21.8% | 272,856 | +1.0% | 0.00% | -25.0% |
| Q3 2021 | $6,662,000 | -1.2% | 270,156 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $6,743,000 | -15.3% | 259,156 | +3.1% | 0.00% | -20.0% |
| Q1 2021 | $7,958,000 | -30.9% | 251,356 | +1.2% | 0.01% | -37.5% |
| Q4 2020 | $11,524,000 | +43.5% | 248,356 | +1.8% | 0.01% | +33.3% |
| Q3 2020 | $8,028,000 | +21.8% | 243,856 | +1.5% | 0.01% | 0.0% |
| Q2 2020 | $6,592,000 | +5.9% | 240,156 | +15.5% | 0.01% | -14.3% |
| Q1 2020 | $6,226,000 | +11.6% | 208,000 | +3.2% | 0.01% | +16.7% |
| Q4 2019 | $5,578,000 | +55.5% | 201,500 | +2.2% | 0.01% | +50.0% |
| Q3 2019 | $3,587,000 | -25.1% | 197,100 | +1.0% | 0.00% | -20.0% |
| Q2 2019 | $4,786,000 | +163.7% | 195,200 | +2.3% | 0.01% | +150.0% |
| Q1 2019 | $1,815,000 | +16.0% | 190,800 | +8.0% | 0.00% | 0.0% |
| Q4 2018 | $1,564,000 | +12.4% | 176,700 | +43.0% | 0.00% | 0.0% |
| Q3 2018 | $1,391,000 | -12.1% | 123,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,582,000 | -24.3% | 123,600 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $2,089,000 | +149.6% | 123,600 | +18.2% | 0.00% | +200.0% |
| Q4 2017 | $837,000 | +3.2% | 104,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $811,000 | +23.8% | 104,600 | +17.4% | 0.00% | 0.0% |
| Q2 2017 | $655,000 | – | 89,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |